APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis

scientific article

APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814
systematic reviewQ1504425

External links are
P356DOI10.1212/WNL.0B013E31829BFDA4
P932PMC publication ID3770168
P698PubMed publication ID23858411

P50authorPerminder SachdevQ7169326
Carole DufouilQ58275775
Lewis KullerQ88077314
Sudha SeshadriQ28516588
Lindsay A. FarrerQ37380266
Kathryn L. LunettaQ37630755
Alexa BeiserQ42561271
Philip A WolfQ42561276
Rhoda AuQ43127298
Anita L DeStefanoQ47502953
Christophe TzourioQ56816583
P2093author name stringKaren A Mather
Wei Wen
Seung Hoan Choi
Bernard Mazoyer
Naftali Raz
José Rafael Romero
Stéphanie Debette
Sabrina Schilling
Peter Høgh
Yi-Cheng Zhu
Charles D DeCarli
P2860cites workChanges in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up StudyQ59542855
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteriaQ73550740
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseQ28238269
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumQ28252389
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association studyQ30425779
Variants at APOE influence risk of deep and lobar intracerebral hemorrhageQ30429407
Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?Q30775068
Silent brain infarcts: a systematic reviewQ31116425
Cerebral microbleeds: a guide to detection and interpretationQ33401999
CadasilQ33470786
Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases.Q33573845
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysisQ33641052
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring StudyQ33762168
MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral HemorrhageQ33855436
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE ConsortiumQ34071362
Genetic variation and neuroimaging measures in Alzheimer diseaseQ34208735
Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variantsQ34213287
Cerebral amyloid angiopathy and vessel dysfunctionQ34568781
Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phaseQ34636326
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortiumQ35065065
Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease.Q35456894
Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?Q35572157
Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls.Q36356533
Brain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik StudyQ36767483
Distribution of white matter hyperintensity in cerebral hemorrhage and healthy agingQ36856068
Neuroimaging and APOE genotype: a systematic qualitative reviewQ36958554
The genetic architecture of intracerebral hemorrhageQ37158275
Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects.Q37465916
Review: sporadic cerebral amyloid angiopathyQ37800132
Apolipoprotein E in Alzheimer's disease and other neurological disordersQ37846932
Genetic associations with brain microbleeds: Systematic review and meta-analyses.Q37895813
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognitionQ43275099
Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study PopulationQ44017324
Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosisQ44756500
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham StudyQ44904997
APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI.Q46794966
Sex differences in the causes and consequences of white matter hyperintensitiesQ46939985
Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits.Q47367180
Interaction between hypertension, apoE, and cerebral white matter lesionsQ47832284
The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 yearsQ48124401
Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin studyQ48143642
Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE studyQ48148055
Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjectsQ48187762
The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensitiesQ48233581
Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.Q48261974
Apolipoprotein E epsilon4 allele is associated with the volume of white matter changes in patients with lacunar infarctsQ48397851
Apolipoprotein E genotype is related to progression of white matter lesion loadQ48498237
Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health StudyQ48530028
Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study.Q48647143
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected populationQ48667530
Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depressionQ48675144
Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention StudyQ48717937
Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlatesQ48868567
Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+).Q48900176
Prevalence and severity of microbleeds in a memory clinic setting.Q51917851
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.Q53229521
Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.Q53235396
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and locationQ57267148
Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated populationQ57621266
Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan StudyQ57621271
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmeta-analysisQ815382
systematic reviewQ1504425
cerebrovascular diseaseQ3010352
P304page(s)292-300
P577publication date2013-07-01
P1433published inNeurologyQ1161692
P1476titleAPOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis
P478volume81

Reverse relations

cites work (P2860)
Q47697118A population neuroscience approach to the study of cerebral small vessel disease in mid- and late-life: an Invited Review
Q46228269APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND.
Q47123978APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease
Q36593238APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL
Q34613047APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
Q90424400APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
Q41449908APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds
Q30825729Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging
Q48148385Affect of APOE on information processing speed in non-demented elderly population: a preliminary structural MRI study
Q37671476Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
Q49156452ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Q92322562Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Q90259358Apolipoprotein E promoter genotypes are not associated with white matter hyperintensity development in high-altitude careers
Q50035045Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response
Q36707857Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer
Q58719840Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function
Q59050338Are the effects ofAPOEϵ4 on cognitive function in nonclinical populations age- and gender-dependent?
Q34116095Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme
Q38748717Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study
Q47105304Background and distribution of lobar microbleeds in cognitive dysfunction.
Q26771852Cerebrovascular disease in ageing and Alzheimer's disease
Q91583670Differential Impact of Plasma Homocysteine Levels on the Periventricular and Subcortical White Matter Hyperintensities on the Brain
Q35203009Diffuse axonal injury at ultra-high field MRI
Q60949811Effects of Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
Q41719695Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation
Q57784857Evaluating apolipoprotein E genotype status and neuroprotective effects against white matter hyperintensity development in high-altitude careers
Q50134655Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories
Q61807445Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting
Q62477928Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms
Q28076438Genetic susceptibility to cerebrovascular disease
Q50207666Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Q38931742Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients
Q37715160Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
Q54974138Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
Q36827380Interarm differences in systolic blood pressure and the risk of dementia and subclinical brain injury
Q34019193Is Alzheimer's disease a systemic disease?
Q37652814Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.
Q64103449Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts
Q35739678Microstructural White Matter Properties Mediate the Association between APOE and Perceptual Speed in Very Old Persons without Dementia
Q61445233Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study
Q33689543Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.
Q88816335Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau
Q36686478Sleep Disordered Breathing and White Matter Hyperintensities in Community-Dwelling Elders.
Q61443837Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort
Q39272772Sydney Memory and Ageing Study: an epidemiological cohort study of brain ageing and dementia
Q26777958The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive Disorders
Q92744517The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population
Q92252120The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)
Q36813704The role of APOE in cerebrovascular dysfunction
Q38206263The role of apolipoprotein E in neurodegeneration and cardiovascular disease
Q36731049The role of cerebrovascular disease when there is concomitant Alzheimer disease
Q89470931Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease
Q35834489Unraveling the potential co-contributions of cerebral small vessel vasculopathy to the pathogenesis of Alzheimer's dementia
Q93132224Vascular Health is Associated with Amyloid-β in Cognitively Normal Older Adults
Q91504592White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants